| First Author | Roche JA | Year | 2008 |
| Journal | Neuroreport | Volume | 19 |
| Issue | 16 | Pages | 1579-84 |
| PubMed ID | 18815587 | Mgi Jnum | J:155857 |
| Mgi Id | MGI:4417877 | Doi | 10.1097/WNR.0b013e328311ca35 |
| Citation | Roche JA, et al. (2008) Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo. Neuroreport 19(16):1579-84 |
| abstractText | The protein, dysferlin, mediates sarcolemmal repair in vitro, implicating defective membrane repair in dysferlinopathies. To study the role of dysferlin in vivo, we assessed contractile function, sarcolemmal integrity, and myogenesis before and after injury from large-strain lengthening contractions in dysferlin-null and control mice. We report that dysferlin-null muscles produce higher contractile torque, and are equally susceptible to initial injury but recover from injury more slowly. Two weeks after injury, control muscles retain fluorescein dextran and do not show myogenesis. Dysferlin-null muscles do not retain fluorescein dextran, and show necrosis followed by myogenesis. Our data indicate that recovery of control muscles from injury primarily involves sarcolemmal repair whereas recovery of dysferlin-null muscles primarily involves myogenesis without repair and long-term survival of myofibers. |
